fda compounding semaglutide crackdown news november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Drug compounders sue FDA over

However, these medications profoundly shift metabolic biomarkers within weeks, including fasting glucose, HbA1c, insulin levels, and lipid profiles, which should be monitored regularly to assess efficacy and safety

It is only available through official clinical trials sponsored by the manufacturer (Eli Lilly)

Bisphenol A (BPA) and phthalates, omnipresent in consumer products ranging from food packaging to personal care items, lead to widespread human exposure, with typical daily intake levels of 0.1-4 g/kg body weight for BPA and 1-20 g/kg body weight for phthalates

Skin camouflage: De-pigmenting the affected epidermis with topical medications such as monobenzone, mequinol or hydroquinone, in instance of a substantial vitiligo

For a patient like this, with prediabetes quickly evolving into diabetes and with troubling arthritis pain, waiting out the shortage of Zepbound wasnt an option in my mind

For people who are in the early weeks of treatment, following the semaglutide week-by-week timeline or tirzepatide weight loss timeline , this protocol should start from day one